Federal Register Notice/Final rule: FDA is amending the animal drug regulations to reflect the withdrawal of approval of 69 NADAs and 22 ANADAs for use of arsanilic acid, carbarsone, or roxarsone Type A medicated articles to manufacture combination drug Type B and Type C medicated feeds. The sponsor has requested this action because the products are no longer manufactured or marketed. To view this notice, click here.
